Skip to main content
OpenTrials

Clinical trial condition

Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7

Explore clinical trials studying Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7 trial results

Completed

Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck

NCT01064479

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +29 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
  • MD Anderson Regional Care Center-Katy Houston, Texas, United States
  • MD Anderson Regional Care Center-Bay Area Nassau Bay, Texas, United States
  • MD Anderson Regional Care Center-Sugar Land Sugar Land, Texas, United States
View Trial Details
Active, Not Recruiting

Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer

NCT02567422

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Carcinoma of Unknown Primary, +17 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
View all 19 locations
View Trial Details

Related conditions